Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...

Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on ...

Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting.

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

I am still struggling to navigate the intrusive questions of well-meaning strangers 17 years after surviving inflammatory ...

Imfinzi with monalizumab and ceralasertib showed promising long-term benefits in advanced NSCLC, but no other combinations ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic ...

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of ...

An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases.

In patients with HR-positive breast cancer who recently gave birth, breastfeeding is OK during a break from receiving hormone ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...